Here are six updates on gastroenterology companies from this week.
Medtronic acquired Crospon Limited, a gastrointestinal device marker, for $45 million.
Cantel Medical reported net sales of $212.76 million in the first quarter of fiscal year 2018.
EndoGastric Solutions recently debuted its EsophyX Z+ device, which is designed for use in transoral incisionless fundoplication procedures.
Lumendi announced the successful completion of the DiLumen Endolumenal Interventional Platform's 100th therapeutic procedure.
Fujifilm Medical Systems U.S.A. partnered with Fight Colorectal Cancer to support the organization's One Million Strong movement, which will bring together more than 1 million U.S.-based colorectal cancer survivors.